RECENT NEWS
bioMérieux invests €9 million in new facility to combat AMR
bioMérieux inaugurated its new Rodolphe Mérieux Campus, in Bagno a Ripoli, Italy during May. The site includes a new R&D centre focusing on the fight against antimicrobial resistance, representing an investment of €9 million.
Ultra-sensitive blood test predicts recurrence of breast cancer
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to detect the presence of tiny amounts of cancer DNA left in the body following treatment for early breast cancer.
Oxera report reveals value of biomedical scientists in NHS
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways, the Institute of Biomedical Science (IBMS) has announced.
Study details potential of blood-based lung cancer screening
DELFI Diagnostics, a developer of blood-based AI tests that deliver a new way to enhance cancer detection, has announced the publication of a study examining the potential of its blood-based cancer screening, ‘Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection’.
Sectra adds IT solution for genomics in cancer diagnostics
Sectra has launched a new diagnostic IT module for genomics within molecular pathology, developed in collaboration with the University of Pennsylvania Health System in the US.
IVDR updates adopted to help prevent shortages
The Council of the EU has formally adopted new rules updating the law on medical devices in order to help prevent shortages and ease the transition to greater transparency and access to information.
Sphere Fluidics accelerates cell line development workflows
Sphere Fluidics, a provider of innovative microfluidics-based solutions for single-cell analysis and isolation, has announced the launch of Cyto-Cellect PLUS. The new assay provides a rapid and cost-effective solution to quantify IgG production in single cells.
eLabNext unveils updated Sample and Inventory System
eLabNext has launched its new Sample and Inventory System, following a comprehensive overhaul which has been driven by extensive customer feedback and the firm’s commitment to enhancing usability, functionality, and integration.
POC test rapidly diagnoses Toxoplasma infections
An inexpensive, accurate test that detects infections with the parasite Toxoplasma gondii can provide results within 30 minutes from a finger-prick in a doctor’s office or within an hour from a small blood sample tested in a local medical laboratory.
NHS patients to access personalised cancer vaccine trials
Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS ‘matchmaking’ service to help find new life-saving treatments.
Paige launches Foundation Model service to support AI models
Digital pathology and AI firm Paige has announced the launch of a new service line based on its Foundation Models, including the world's largest multi-modal AI model in pathology and oncology.
WHO updates list of drug-resistant bacteria most threatening to human health
The World Health Organization (WHO) has released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritisation. The list provides guidance on the development of new and necessary treatments to stop the spread of antimicrobial resistance (AMR).
Everything you need to know about NGS
INTEGRA Biosciences has released a new eBook providing a complete guide to next generation sequencing (NGS).
Bosch launches PCR rapid test for Candida auris
Bosch Healthcare Solutions has developed a PCR test for detecting Candida auris (C. auris) on the Vivalytic platform. The test is a global innovation now available for order from distribution partners including Randox Laboratories and R-Biopharm.
Collaboration aims to detect oral cavity cancer from saliva
Jerusalem-based startup Salignostics, which develops and provides rapid tests based on saliva samples, has signed a cooperation agreement with ARC Innovation - the innovation arm of Sheba Medical Center. The agreement aims to develop a test for detecting oral cavity cancer based on saliva samples.
New study applies Microsoft AI to pathology
A joint study carried out by US health group Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes and advance individually tailored care has been published in Nature.
New technique detects novel biomarkers for kidney diseases with nephrotic syndrome
A study, presented at the 61st European Renal Association (ERA) Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome.
Official opening for Dorset Pathology Hub
A 'new era' in medical diagnostics and patient care in Dorset was celebrated as NHS staff and partners gathered recently, to witness patient Steve Hiorns officially open the state-of-the-art Dorset Pathology Hub.
Nanopath secures grants to continue developing diagnostics for women
Point-of-care diagnostics company Nanopath has been awarded $4 million in funding from US Federal agencies. The company was awarded a $3 million grant from the National Institutes of Health (NIH) and a $1 million grant from the National Science Foundation (NSF) to support continued research and development of the company's point-of-care diagnostic platform for pelvic and gynaecologic infections.
Roche and Hitachi High-Tech extend 46-year partnership
Roche and Hitachi High-Tech have announced the extension of the partnership between the two companies, committing to at least 10 years of additional collaboration. Bringing together Roche and Hitachi’s expertise and track record in diagnostics innovation, engineering and manufacturing, the renewed contract further strengthens the long-lasting partnership.
Latest Issues
HORIBA Medical is a renowned specialist in the design and manufacture of automated in-vitro diagnostic systems for analysis in haematology, clinical chemistry, and haemostasis. From compact point of care (POC) solutions to high throughput laboratory systems, HORIBA Medical has successfully developed an array of analysers and data management...
UKHSA Conference 2025
Manchester Central
25-26 March, 2025
Microbiology Society Annual Conference 2025
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
2nd Global Summit on Pathology
Rome, Italy
10-11 April, 2025
Clinical Innovations EXPO - Breaking Through the Adoption Barriers
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
BSMT Annual Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025